The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
January 29th 2025
Through similar targeting of the RdRp enzyme, these treatments could offer groundbreaking new options for patients with COVID-19 if proven effective in real-world trials.
Genzyme Seeks Approval for Multiple Sclerosis Drug Lemtrada
June 20th 2012Sanofi's Genzyme unit announced in a press release earlier last week that the company has submitted an application to regulatory authorities for approval of Lemtrada (alemtuzumab) for the treatment of relapsing multiple sclerosis (RMS).
Read More
Alzheimer's Association Launches "The Longest Day" Event
June 18th 2012On June 20th, 2012, the longest day of the year, the Alzheimer's Association is asking participants to run, walk, bike, or engage in some kind of endurance activity for 16 consecutive hours to honor those facing Alzheimer's disease.
Read More
SXC Health Solutions Receives URAC Specialty Pharmacy Accreditation
June 18th 2012SXC Health Solutions Corp announced that it has been awarded Specialty Pharmacy Accreditation from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry.
Read More
Phase 3 study findings showed that patients with active moderate to severe rheumatoid arthritis (RA) who received an investigational intravenous (IV) formulation of the anti-tumor necrosis factor (TNF)-alpha therapy Simponi (golimumab) demonstrated significant improvements in signs, symptoms, and disease activity.
Read More
Argus Expands Specialty Pharmacy with Amber Pharmacy Collaboration
June 13th 2012Argus Health Systems, Inc, a leading transparent pharmacy benefits administrator, recently announced that it has established a Preferred Specialty Program with Amber Pharmacy to provide expanded network options.
Read More
FDA Approves Genentech, Inc's Perjeta for HER2-Positive Metastatic Breast Cancer
June 11th 2012The FDA approved Genentech, Inc's pertuzumab injection (Perjeta) for use in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
Read More
Diplomat Specialty Pharmacy Names Industry Veteran, Gary Kadlec, New Company President
June 11th 2012Diplomat Specialty Pharmacy, the nation's largest, privately owned specialty pharmacy, announced that pharmacy executive, Gary W. Kadlec, has joined the company and will be serving as president.
Read More
New efficacy and safety data from the Phase 3 PHOENIX 1 study, 1 of 2 pivotal registration trials, showed that maintenance treatment with Stelara (ustekinumab) for up to 5 years resulted in consistent, significant clinical response in adults with moderate to severe plaque psoriasis.
Read More
Cardinal Health Specialty Solutions Launches PathWare Decision Support Transaction Solutions
May 29th 2012Cardinal Health Specialty Solutions today launched PathWare Decision Transaction Solutions, a new technology system that makes it easier for payors and physicians to work together to implement programs that improve the quality and cost of caring for patients.
Read More